Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
SURI vs NTIIX
Shared holdings
1
SURI covered by NTIIX
9.73%
NTIIX covered by SURI
9.73%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 43 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
SURI (March 31, 2026)
| Security | Weight | |
|---|---|---|
| U.S. Treasury Bills | 48.56% | |
| Plains GP Holdings LP LTD PARTNER INT CL A NEW IN | 23.28% | |
| ACHIEVE LIFE SCIENCES INC | 2.62% | |
| PHATHOM PHARMACEUTICALS INC | 2.20% | |
| DELCATH SYSTEMS | 1.83% | |
| ABEONA THERAPEUTICS INC | 1.69% | |
| CELLDEX THERAPEUTICS INC | 1.65% | |
| MILESTONE PHARMACEUTICALS INC | 1.35% | |
| OCULIS HOLDING AG | 1.34% | |
| LEONABIO INC | 1.16% | |
| CORCEPT THERAPEUTICS INC | 1.15% | |
| KYVERNA THERAPEUTICS INC | 1.13% | |
| INVENTIVA SA UNSPON ADR | 0.95% | |
| VIRIDIAN THERAPEUTICS INC | 0.83% | |
| AQUESTIVE THERAPEUTICS INC | 0.73% | |
| VOR BIOPHARMA INC | 0.72% | |
| ORCHESTRA BIOMED HOLDINGS INC | 0.70% | |
| ZEVRA THERAPEUTICS INC | 0.68% | |
| COMPASS Pathways PLC, ADR | 0.66% | |
| TELESAT CANADA/TELESAT L REGD 144A P/P 5.62500000 | 0.60% | |
| TREVI THERAPEUTICS INC | 0.59% | |
| OCULAR THERAPEUTIX INC | 0.57% | |
| SAB BIOTHERAPEUTICS INC | 0.54% | |
| UPSTREAM BIO INC | 0.53% | |
| EYEPOINT PHARMACEUTICALS INC | 0.52% | |
| 4D MOLECULAR THERAPEUTICS INC | 0.49% | |
| PALISADE BIO INC | 0.46% | |
| ZEALAND PHARMA A | 0.43% | |
| KALARIS THERAPEUTICS INC | 0.38% | |
| IMMUNIC INC | 0.37% | |
| COHERUS ONCOLOGY INC | 0.32% | |
| NOVO NORDISK CVR | 0.32% | |
| CORVUS PHARMACEUTICALS INC | 0.22% | |
| OVID THERAPEUTICS INC | 0.22% | |
| ARTIVA BIOTHERAPEUTICS INC | 0.11% | |
| CONNECT BIOPHARMA HOLDINGS LTD | 0.11% | |
| Contra Chinook Therape, CVR | 0.00% | |
| EIGER BIOPHARMACEUTICALS INC | 0.00% | |
| MILESTONE PHARMACE WTS | 0.00% | |
| Achieve Life Science Inc WT EXP 063030 | 0.00% | |
| JASPER THERAPEUTIC WTS | 0.00% | |
| WTS - TENAYA THERAPEUTICS | 0.00% | |
| QUOIN PHARMACEUTIC WTS | 0.00% |
NTIIX (April 30, 2026)
| Security | Weight | |
|---|---|---|
| Short-Term Investment | 31.74% | |
| UST BILLS 0% 05/14/2026 | 9.77% | |
| U.S. Treasury Bills | 9.77% | |
| U.S. Treasury Bills | 9.76% | |
| U.S. Treasury Bills | 9.75% | |
| U.S. Treasury Bills | 9.75% | |
| U.S. Treasury Bills | 9.74% | |
| U.S. Treasury Bills | 9.73% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.